KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Non-Current Assets (2016 - 2025)

Boston Scientific's Non-Current Assets history spans 17 years, with the latest figure at $34.9 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 7.4% year-over-year to $34.9 billion; the TTM value through Dec 2025 reached $94.1 billion, up 13.82%, while the annual FY2025 figure was $34.9 billion, 7.4% up from the prior year.
  • Non-Current Assets for Q4 2025 was $34.9 billion at Boston Scientific, up from -$8.0 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $34.9 billion in Q4 2025 and bottomed at -$8.0 billion in Q3 2025.
  • The 5-year median for Non-Current Assets is $26.9 billion (2022), against an average of $17.8 billion.
  • The largest annual shift saw Non-Current Assets fell 13.65% in 2021 before it increased 28.44% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $20.8 billion in 2021, then rose by 28.44% to $26.7 billion in 2022, then grew by 7.16% to $28.6 billion in 2023, then rose by 13.46% to $32.5 billion in 2024, then grew by 7.4% to $34.9 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Non-Current Assets are $34.9 billion (Q4 2025), -$8.0 billion (Q3 2025), and $34.4 billion (Q2 2025).